15 research outputs found
Additional file 2: of Partner HIV serostatus disclosure and determinants of serodiscordance among prevention of mother to child transmission clients in Nigeria
HIVQual sample size determination chart based on 95Â % CI. (PDF 173Â kb
Additional file 1: of Partner HIV serostatus disclosure and determinants of serodiscordance among prevention of mother to child transmission clients in Nigeria
Study regions and state. (PDF 373Â kb
Overall outcome of the pilot study within the review period.
<p>Overall outcome of the pilot study within the review period.</p
Proportion of drugs for multi-drug resistant tuberculosis consumed at the treatment centre level out of the total quantity allocated for routine consumption, Nigeria, 2013 (Target = 100%).
<p>Proportion of drugs for multi-drug resistant tuberculosis consumed at the treatment centre level out of the total quantity allocated for routine consumption, Nigeria, 2013 (Target = 100%).</p
Proportion of drugs for multidrug resistant tuberculosis ordered at the central level, out of the quantity forecasted for 2013, Nigeria (Target = 100%).
<p>Proportion of drugs for multidrug resistant tuberculosis ordered at the central level, out of the quantity forecasted for 2013, Nigeria (Target = 100%).</p
Proportion of treatment centres (n = 7) that placed an order for multi-drug resistant tuberculosis drugs when there was less than three months of stock (Target = 0%).
<p>Proportion of treatment centres (n = 7) that placed an order for multi-drug resistant tuberculosis drugs when there was less than three months of stock (Target = 0%).</p
Six early-warning indicators of stock-out and overstocking of the Procurement and Supply Management System (PSM) for MDR-TB drugs in Nigeria.
<p>Adapted from reference 4</p><p>Six early-warning indicators of stock-out and overstocking of the Procurement and Supply Management System (PSM) for MDR-TB drugs in Nigeria.</p
Distribution by Anatomical Site and Pathological Diagnosis of Final Sample (n = 17).
<p>Distribution by Anatomical Site and Pathological Diagnosis of Final Sample (n = 17).</p
General Characteristics of Samples Tested for HBV DNA (n = 17).
<p>General Characteristics of Samples Tested for HBV DNA (n = 17).</p